H&H Bioengineering has been deeply involved in the international high-quality probiotic raw material market, always prioritizing quality and safety, practicing quality management and compliant operation with a long-term perspective, and winning the trust of global customers with its professional and reliable manufacturing capabilities.
Long-term commitment builds a monument to quality.
First in China! H&H Bioengineering's probiotic production base passes US FDA review with "zero defects"

Recently, Zhengzhou H&H Bioengineering Co., Ltd. officially received the Enterprise On-site Inspection Report (EIR) issued by the U.S. Food and Drug Administration (FDA).

From September 21st to 22nd, 2026, H&H Bioengineering's probiotic production base in Zhengzhou, Henan Province, underwent an on-site inspection by the U.S. FDA. Inspectors conducted a thorough review of the entire probiotic production process, from strain preparation, high-density fermentation, centrifugation concentration, emulsification protection, low-temperature freeze-drying to subsequent formulation processing.
At the conclusion of the review, the inspector did not issue Form FDA 483, meaning no formal review observations were raised, and no issues required discussion with the company. Subsequently, the FDA officially issued an Enterprise On-Site Inspection Report (EIR) to H&H Bioengineering.
This "zero-defect" passing of the US FDA on-site inspection is a significant testament to H&H Bioengineering's long-standing commitment to high-standard quality management. As the first probiotic raw material manufacturer in China to achieve this result, this milestone not only demonstrates H&H Bioengineering's achievements in aligning with international standards in manufacturing and quality management, but also reflects the ability of Chinese probiotic raw material manufacturers to continuously improve product quality and safety management, actively participate in international market competition, and boost confidence in the global market for high-quality domestically produced probiotic raw materials.

What exactly makes achieving zero defects so difficult?
Many people believe that FDA on-site inspections mainly focus on the factory's hygiene conditions and production environment. In reality, for probiotic manufacturers, FDA on-site inspections are not simply document reviews, but rather a thorough examination of the production site, delving into the company's daily production operations. They conduct on-site verification of production operations, equipment and facilities, personnel management, process execution, and quality control, and, in conjunction with relevant documents and records, assess whether the company's various management requirements are truly implemented in production practice.
During this on-site inspection, FDA inspectors conducted a comprehensive review of H&H Bioengineering's production operations and quality management, focusing on key aspects such as production practices, food safety, hygiene management, and quality control. The review covered multiple areas.
- Standardized Production Management (cGMP): Standardized management of raw material receiving, production operations, equipment management, and finished product release.
- Hazard Analysis and Prevention Program (HARPC): Hazard analysis, risk-based preventative control measures, and their implementation.
- Hygiene and Environmental Control: Cleaning and disinfection of production equipment, personnel hygiene, and management of the production environment.
- Production Process Control: Critical process parameters, production conditions, equipment calibration, and process records.
- Allergen Management: Management of raw materials and excipients, and prevention of cross-contamination.
- Supply Chain and Record Management: Supplier management, raw material traceability, production batch records, personnel training, and related quality records.
For probiotics, a special category, production quality management has its own specific requirements, such as:
- Strain identification management: Ensuring accurate strain identification and avoiding strain confusion and labeling errors.
- Live bacteria count quality control: Establishing accurate and reliable testing methods to ensure products meet corresponding quality specifications.
- Production environment control: Strengthening microbial management of the production environment to reduce the risk of contamination during production.
- Key process control: Paying attention to the impact of processes such as fermentation, centrifugation, and low-temperature freeze-drying on product quality and live bacteria stability.
Therefore, the FDA on-site inspection tests not only whether a company has comprehensive management documentation, but also whether it can truly implement quality standards in every production process and every management detail, and maintain this level of commitment in daily operations. The results of this inspection are a significant demonstration of H&H Bioengineering's long-standing commitment to standardized production, strict quality control, and continuous improvement.

Build an international quality management system to ensure product quality and safety.
Deepen international market presence and solidify compliance foundation
For a long time, H&H Bioengineering has been deeply rooted in the high-quality raw material markets of Europe and the United States, continuously serving customers in the global nutrition and health industry. In mature markets such as Europe and the United States, customers' requirements for probiotic raw materials are not only reflected in strain performance, live bacteria count, and product application value, but also involve the safety of raw materials, the standardization of the production process, the stability of product quality, and the quality management capabilities of suppliers.
As early as 2019, H&H Bioengineering's production base began the FDA food facility registration process in the United States, continuously promoting compliance construction for the international market. We deeply understand that high-quality probiotic raw materials require not only excellent strains and advanced R&D technology, but also a rigorous, standardized, and continuously improving production management system. Focusing on key indicators such as strain characteristics, raw material quality, product specifications, and storage stability, the company continuously improves its product quality control requirements, attaches great importance to quality management in all aspects from R&D to manufacturing, and strives to provide customers with stable, safe, and reliable probiotic and postbiotic products.

System construction and continuous improvement
H&H Bioengineering continuously improves its quality management system, actively aligning with international quality and food safety management standards, and has built a multi-level management system covering production, quality control, and food safety management.
Currently, the company's relevant production systems and products involve the following quality management standards and international certifications:
cGMP (Current Good Manufacturing Practice): Emphasizing standardized management of the production process, quality control, and production record management.
HACCP (Hazard Analysis and Critical Control Points): Managing food safety risks and key control points in the production process.
ISO 9001 (Quality Management System): Continuously improving quality management processes and process control capabilities.
ISO 22000 (Food Safety Management System): Strengthening food safety risk management and improving the safety management level of the food production process.
FSSC 22000 (Food Safety System Certification): Continuously improving food safety management and production operations in accordance with international food safety system certification requirements.
HALAL (Halal Certification): Meeting relevant halal certification requirements to provide corresponding product support to customers in different markets.
KOSHER certification: Meeting relevant kosher certification requirements supports product access to more international markets and diversified application scenarios.
Successfully passing the US FDA review is a significant milestone in the company's long-term investment in quality management and manufacturing capabilities.
Deeply rooted in the international market, empowering global partners with professional manufacturing capabilities.
Global service system construction
With the continuous development of the global probiotic and post-biotic industry, international brand owners, dietary supplement manufacturers, and raw material distributors are increasingly sophisticated in their supplier evaluations. Customers are no longer solely focused on company size, brand awareness, or product endorsements when choosing suppliers; they increasingly value a company's genuine R&D capabilities, production management level, quality control capabilities, regulatory compliance, and long-term stable supply guarantees.
For a long time, Hehe Biotech has been committed to providing the global nutrition and health industry with professional probiotic and post-biotic raw materials and customized manufacturing services.
- Raw Material Supply: Providing a diverse range of probiotic and post-biotic raw materials to meet different product development and application needs.
- R&D Support: Leveraging its own R&D capabilities, providing customers with strain application, product development, and related technical support.
- Customized Manufacturing: Supporting product development and OEM/ODM cooperation for different specifications, dosage forms, and application scenarios.
- Quality and Regulatory Documentation Support: Providing relevant product technical data, quality documents, and compliance support based on customer and target market requirements.
Passing the FDA review further strengthens Hehe Bio's ability to demonstrate its production quality management capabilities to international customers, and also provides new impetus for the company to deepen cooperation in the European and American markets and expand its global high-quality raw material business.
Adhering to long-termism, winning the trust of global customers through quality.
From "Made in China" to the global market, quality and safety have always been the foundation of H&H Bioengineering's development. This "zero-defect" FDA approval is a significant milestone in the company's long-term commitment to high-standard quality management and a new starting point for continuously improving its R&D and manufacturing capabilities.
In the future, H&H Bioengineering will continue to be guided by the needs of international market customers, driven by R&D innovation, based on manufacturing, and with quality and safety at its core. It will continuously improve its R&D, production, and application capabilities for probiotics and post-biotic raw materials, creating long-term value for customers through stable quality, rigorous production management, and a continuously improving quality philosophy.





